(Q44105420)

English

The effect of pharmacokinetic/pharmacodynamic (PK/PD) parameters of gatifloxacin on its bactericidal activity and resistance selectivity against clinical isolates of Streptococcus pneumoniae

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

The effect of pharmacokinetic/pharmacodynamic (PK/PD) parameters of gatifloxacin on its bactericidal activity and resistance selectivity against clinical isolates of Streptococcus pneumoniae (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Hiroyuki Ebisu

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ryuta Kishii

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Masaya Takei

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hideyuki Fukuda

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14513387

15 March 2024

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1341321X04711228?httpAccept=text/xml

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

https://api.elsevier.com/content/article/PII:S1341321X04711228?httpAccept=text/plain

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

http://www.springerlink.com/index/pdf/10.1007/s10156-003-0243-9

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Journal of Infection and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

210-214

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

https://scigraph.springernature.com/pub.10.1007/s10156-003-0243-9

0 references

In vitro antimicrobial activity of gatifloxacin against 873 clinical isolates from respiratory tract, urinary tract and surgical infections during 1997-1998 in Japan

1

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

2

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone

3

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

4

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication

5

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model

7

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model

8

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae

9

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

In vitro characterization of fluoroquinolone concentration/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae.

10

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

The effect of pharmacokinetics on the bactericidal activity of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae and the emergence of resistance

11

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.

12

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Primary targets of fluoroquinolones in Streptococcus pneumoniae.

16

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae

18

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

19

1 reference

10.1007/S10156-003-0243-9

https://api.crossref.org/works/10.1007/S10156-003-0243-9

15 March 2024

Identifiers

10.1007/S10156-003-0243-9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44105420&oldid=2144675594"